TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

13.30$ +0.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement AMRN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +50.8% +59.1% +39.2% +26.6% +87.5% +42.9% -5.0% -36.7% -16.9% -25.5% -6.5%
– +36.1% +23.3% +30.8% +21.3% +76.0% +36.9% -7.7% +4.4% +11.6% +4.1% -37.0%
– +59.8% +77.7% +42.2% +28.3% +91.1% +44.6% -4.3% -47.5% -31.7% -50.8% +48.5%
– +1.5% -2.1% -5.6% +18.5% -38.5% +13.3% -24.8% +3.8% -26.9% -6.1% -5.1%
– +17.3% +0.3% +20.0% +60.8% +79.6% -65.2% +25.9% -16.3% -25.4% -17.9% +2.3%
– +17.3% +6.1% +12.6% +55.7% +26.6% +40.3% -10.1% -22.8% -36.2% -22.0% -22.2%
– – – – – – – – -1,108.1% – – –
– +8.5% -6.8% -47.7% -9.2% -25.3% -60.7% -95.0% -88.4% -46.7% -12.5% +0.0%
– – – – – – – – -1,019.4% – – –
– – – +30.9% -99.3% +70.8% +354.3% +378.1% -43.9% +172.4% -8.4% -44.8%
– – – – – – – – -1,468.9% – – –
– – – – – – – – -805.4% – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?